SCHEMBL15218699

SCHEMBL15218699

CC(C)CSc1ccc(/N=N/c2ccc(C(=O)O)cc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.51
POLB P06746 3/20 0.49
NPC1 O15118 3/20 0.49
KMT2A Q03164 2/20 0.49
MEN1 O00255 1/20 0.49
HTT P42858 2/20 0.43
CD69 Q07108 1/20 0.43
MAPT P10636 5/20 0.41
NOS1 P29475 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
ATM Q13315 1/20 0.41
GAA P10253 3/20 0.40
MAPK1 P28482 1/20 0.40
MTNR1A P48039 3/20 0.39
MTNR1B P49286 3/20 0.39
RAB9A P51151 3/20 0.39
ALDH1A1 P00352 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6487970 0.90 HTT (0.50) KMT2AHTTMAPTMAPK1MTNR1A
SCHEMBL15209410 0.82 MAOA (0.48) TRPA1NPC1KMT2AMEN1HTT
SCHEMBL15218700 0.81 RAB9A (0.55) POLBNPC1KMT2AMEN1HTT
SCHEMBL15218698 0.79 TRPA1 (0.56) TRPA1POLBNPC1KMT2AMEN1
SCHEMBL31632675 0.78 HTT (0.49) KMT2AHTTMAPTMAPK1MTNR1A
SCHEMBL15218701 0.76 TAS1R3 (0.40) NPC1KMT2AMEN1HTTMAPT
SCHEMBL1548150 0.76 TRPA1 (0.62) TRPA1POLBNPC1KMT2AMEN1
SCHEMBL1548149 0.76 TRPA1 (0.62) TRPA1POLBNPC1KMT2AMEN1
SCHEMBL31702246 0.75 TRPA1 (0.86) TRPA1POLBNPC1KMT2AMEN1
SCHEMBL70162 0.75 TRPA1 (0.86) TRPA1POLBNPC1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9018362-B2 Oligonucleotide and use thereof NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) 2015-04-28 US disclosed
US-9018362-B2 Oligonucleotide and use thereof NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) 2015-04-28 US disclosed
US-20130225797-A1 OLIGONUCLEOTIDE AND USE THEREOF NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) 2013-08-29 US disclosed
US-20130225797-A1 OLIGONUCLEOTIDE AND USE THEREOF NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) 2013-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130225797-A1 OLIGONUCLEOTIDE AND USE THEREOF NOP2, HNRNPA2B1, NSUN2 TRPA1 3471/4885POLB 6/4885NPC1 3221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.